Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cancer Genetics Inc (NASDAQ:CGIX)

2.14
Delayed Data
As of May 25
 0.00 / 0.00%
Today’s Change
1.90
Today|||52-Week Range
12.75
-35.15%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues4.3M6.6M10.2M18.0M
 
 
 
 
 
Cost of Goods Sold3.6M4.6M7.6M12.4M
 
 
 
 
 
Depreciation And Amortization353.4K326.5K838.6K1.7M
 
 
 
 
 
 
Operating ExpensesGross Income372.6K1.7M1.7M3.9M
 
 
 
 
 
General Expenses8.0M9.5M20.0M23.9M
 
 
 
 
 
Research And Development2.1M2.2M3.7M4.8M
 
 
 
 
 
Total Operating Expenses11.9M14.5M28.5M38.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.6M-7.8M-18.3M-20.0M
 
 
 
 
 
Extraordinary Credit7.5M4.6M615.0K511.0K
 
 
 
 
 
Extraordinary Charge-1.9M-7.5M0.00-890.0K
 
 
 
 
Pre-Tax Equity Earnings0.00---939.9K-707.0K
 
 
 
Interest Expense On Debt4.7M2.4M472.8K344.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.7M-13.0M-19.0M-21.4M
 
 
 
 
 
Income Taxes0.00-663.9K-2.4M-1.2M
 
 
 
 
Net Income-6.7M-12.4M-16.6M-20.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS4.0M4.7M9.4M10.3M
 
 
 
 
 
Shares To Calculate EPS Diluted4.0M4.7M9.5M10.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$10.55-$3.64-$1.80-$1.96
 
 
 
 
 
EPS Diluted-$3.54-$3.64-$1.80-$1.96